Zobrazeno 1 - 10
of 1 808
pro vyhledávání: '"Odenike, O"'
Autor:
Garcia JS; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Platzbecker U; University Hospital Leipzig, Department of Hematology and Cell Therapy, Leipzig, Germany., Odenike O; University of Chicago, Department of Medicine, Section of Hematology/Oncology, Chicago, Illinois, United States., Fleming SA; Alfred Hospital, Melbourne, Australia., Fong CY; Austin Health, Heidelberg, Australia., Borate U; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States., Jacoby MA; Washington University School of Medicine, St. Louis, Missouri, United States., Nowak D; Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Baer MR; University of Maryland, Baltimore, Maryland, United States., Peterlin P; Nantes University Hospital, NANTES, France., Chyla B; AbbVie Inc, North Chicago, IL, United States., Wang H; AbbVie Inc, North Chicago, IL, United States., Ku G; Genentech, Inc., South San Francisco, California, United States., Hoffman D; AbbVie Inc, North Chicago, IL, United States., Potluri J; AbbVie Inc, North Chicago, IL, United States., Garcia-Manero G; AbbVie Inc, North Chicago, IL, United States.
Publikováno v:
Blood [Blood] 2024 Dec 09. Date of Electronic Publication: 2024 Dec 09.
Autor:
Lin C; The University of Chicago Pritzker School of Medicine, Chicago, IL., Patel AA; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Huo D; Department of Public Health Sciences, The University of Chicago, Chicago, IL., Karrison T; Department of Public Health Sciences, The University of Chicago, Chicago, IL., van Besien K; Division of Hematology and Cellular Therapy, University Hospitals Cleveland Medical Center, Cleveland, OH., Godwin J; Earle A. Chiles Research Institute, Providence Portland Cancer Institute, Portland, OR., Sher D; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Weiner H; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Green M; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Wade JL 3rd; Medical Oncology, Decatur Memorial Hospital, Decatur, IL., Klisovic R; Division of Hematology & Medical Oncology, Emory University School of Medicine, Atlanta, GA., Baer MR; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD., Larson RA; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL.; The University of Chicago Comprehensive Cancer Center, Chicago, IL., Stock W; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Odenike O; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL.
Publikováno v:
Blood advances [Blood Adv] 2024 Nov 26; Vol. 8 (22), pp. 5735-5743.
Autor:
Komrokji RS; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lanino L; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Ball S; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marchetti M; Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Maggioni G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Travaglino E; IRCCS Polilcinico San Matteo, Pavia, Italy., Al Ali NH; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Fenaux P; Saint Louis Hospital, Paris Cité University, Paris, France., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Santini V; University of Florence, Florence, Italy., Diez-Campelo M; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Singh A; Cleveland Clinic, Cleveland, OH, USA., Jain AG; Cleveland Clinic, Cleveland, OH, USA., Aguirre LE; Dana Farber Cancer Institute, Boston, MA, USA., Tinsley-Vance SM; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Schwabkey ZI; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chan O; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xie Z; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Brunner AM; Dana Farber Cancer Institute, Boston, MA, USA., Kuykendall AT; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Bennett JM; University of Rochester Medical Center, Rochester, NY, USA., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Bejar R; University of California San Diego, San Diego, CA, USA., Carraway HE; Cleveland Clinic, Cleveland, OH, USA., DeZern AE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Halene S; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Hasserjian RP; Massachusetts General Hospital, Boston, MA, USA., Lancet J; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., List AF; Precision BioSciences, Durham, NC, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Roboz GJ; New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA., Stahl M; Dana Farber Cancer Institute, Boston, MA, USA., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Steensma DP; Ajax Therapeutics, Cambridge, MA, USA., Savona MR; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Xu ML; Department of Pathology and Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA., Sweet K; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Hourigan CS; Virginia Tech FBRI Cancer Research Center, Washington, DC, USA., Wei AH; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sauta E; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., D'Amico S; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Train, Milan, Italy., Asti G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Castellani G; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Delleani M; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Campagna A; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Borate UM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Sanz G; Instituto de Salud Carlos III, Valencia, Spain., Efficace F; Department of Haematology, La Fe University and Polytechnic Hospital, Valencia, Spain., Gore SD; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Kim TK; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rozman M; Hospital Clínic Barcelona, Barcelona, Spain., Orfao A; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Foucar MK; University of New Mexico, Albuquerque, NM, USA., Germing U; Department of Haematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Scheinberg P; Beneficência Portuguesa de São Paulo Hospital, São Paulo, Brazil., Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Iastrebner M; Sanatorio Sagrado Corazón, Buenos Aires, Argentina., Kulasekararaj A; King's College Hospital NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK., Cluzeau T; Nice University Hospital, Nice, France., Kordasti S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College, London, UK., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center-Cancer Center, Amsterdam, Netherlands., Ades L; Saint Louis Hospital, Paris Cité University, Paris, France., Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Della Porta MG; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.eu.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Nov; Vol. 11 (11), pp. e862-e872. Date of Electronic Publication: 2024 Oct 09.
Autor:
Roloff GW; Section of Hematology/Oncology, University of Chicago., Kosuri S; Section of Hematology/Oncology, University of Chicago., Nawas MT; Section of Hematology/Oncology, University of Chicago., DuVall AS; Section of Hematology/Oncology, University of Chicago., Patel AA; Section of Hematology/Oncology, University of Chicago., Riedell PA; Section of Hematology/Oncology, University of Chicago., Odenike O; Section of Hematology/Oncology, University of Chicago., Stock W; Section of Hematology/Oncology, University of Chicago., Larson RA; Section of Hematology/Oncology, University of Chicago., Bishop MR; Section of Hematology/Oncology, University of Chicago., Nunley E; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Godley LA; Division of Hematology/Oncology, Northwestern Medicine, Chicago IL., Hathaway F; Section of Hematology/Oncology, University of Chicago., Del Gaudio D; Division of Pathology, University of Chicago., Das S; Division of Pathology, University of Chicago., Canham LE; Section of Pediatric Hematology/Oncology, University of Chicago. lorraine.canham@bsd.uchicago.edu., Drazer MW; Section of Hematology/Oncology, University of Chicago. michaeldrazer@uchicagomedicine.org.
Publikováno v:
Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3739-3744. Date of Electronic Publication: 2024 Nov 01.
Autor:
Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Barosi G; Department of Hematology, Center for the Study of Myelofibrosis, IRCCS Policlinico S Matteo Foundation, Pavia, Italy., Passamonti F; Dipartimento di Oncologia ed Onco-Ematologia, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Hernandez-Boluda JC; Haematology Department, Hospital Clínico Universitario, Instituto de Investigación Sanitaria, Valencia, Spain., Bose P; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Ellis M; Department of Hematology, Hematology Institute, Meir Medical Center, Tel Aviv University, Tel Aviv, Israel., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gisslinger H; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria., Gotlib J; Department of Hematology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Guglielmelli P; Department of Hematology, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy., Gupta V; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Harrison C; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Hexner EO; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA., Hobbs GS; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Kiladjian JJ; Department of Hematology, Centre d'Investigations Cliniques Hôpital Saint-Louis, Université Paris Cité, Paris, France., Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Aachen, Germany., Kroger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kuykendall AT; Department of Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Loscocco GG; Department of Hematology, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy., Mascarenhas J; Division of Hematology and Oncology, Department of Internal Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Masarova L; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Mesa R; Department of Hematology, Levine Cancer Institute, Charlotte, NC., Mora B; Dipartimento di Oncologia ed Onco-Ematologia, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Odenike O; Department of Hematology, Leukemia Program, University of Chicago Medicine, University of Chicago Comprehensive Cancer Center, Chicago, IL., Oh ST; Division of Hematology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Patel A; Department of Hematology, Leukemia Program, University of Chicago Medicine, University of Chicago Comprehensive Cancer Center, Chicago, IL., Pemmaraju N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Rambaldi A; Department of Oncology and Hematology, University of Milan, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Rampal R; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY., Sirhan S; Department of Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada., Szuber N; Department of Hematology, Maisonneuve-Rosemont Hospital, University of Montreal, Quebec, QC, Canada., Talpaz M; Department of Hematology-Oncology, University of Michigan, Ann Arbor, MI., Vachhani PJ; Department of Medicine, Division of Hematology and Oncology, The University of Alabama at Birmingham, Birmingham, AL., Vannucchi AM; Department of Hematology, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy., Barbui T; Department of Hematology, FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Publikováno v:
Blood [Blood] 2024 Oct 24; Vol. 144 (17), pp. 1813-1820.
Autor:
Hoff FW; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Blum WG; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Huang Y; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Welkie RL; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Swords RT; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Traer E; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Stein EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Lin TL; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City, KS., Archer KJ; Division of Biostatistics, The Ohio State University, Columbus, OH., Patel PA; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Collins RH; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Baer MR; Department of Medicine, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD., Duong VH; Department of Medicine, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD., Arellano ML; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Stock W; Department of Medicine, The University of Chicago, Chicago, IL., Odenike O; Department of Medicine, The University of Chicago, Chicago, IL., Redner RL; Department of Medicine, University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA., Kovacsovics T; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT., Deininger MW; Department of Internal Medicine, Versiti Blood Research Institute and Medical College of Wisconsin, Milwaukee, WI., Zeidner JF; Division of Hematology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Olin RL; Department of Medicine, University of California, San Francisco, San Francisco, CA., Smith CC; Department of Medicine, University of California, San Francisco, San Francisco, CA., Foran JM; Department of Internal Medicine, Mayo Clinic, Jacksonville, FL., Schiller GJ; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA., Curran EK; Deparrtment of Internal Medicine, University of Cincinnati, Cincinnati, OH., Koenig KL; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Heerema NA; Department of Pathology, The Ohio State University, Columbus, OH., Chen T; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Martycz M; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Stefanos M; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Marcus SG; Leukemia & Lymphoma Society, Rye Brook, NY., Rosenberg L; Leukemia & Lymphoma Society, Rye Brook, NY., Druker BJ; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Levine RL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Burd A; Leukemia & Lymphoma Society, Rye Brook, NY., Yocum AO; Leukemia & Lymphoma Society, Rye Brook, NY., Borate UM; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Mims AS; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Byrd JC; Deparrtment of Internal Medicine, University of Cincinnati, Cincinnati, OH., Madanat YF; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Publikováno v:
Blood advances [Blood Adv] 2024 Oct 22; Vol. 8 (20), pp. 5297-5305.
Autor:
Aakash F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology, University of Texas Medical Branch, Galveston, Texas., Gisriel SD; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin., Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut., Bennett JM; James P. Wilmot Cancer Center, Division of Hematopathology, University of Rochester Medical Center, Rochester, New York., Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, California., Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York., Borate UM; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Boultwood J; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Brunner AM; Division of Hematology, Massachusetts General Hospital Brigham, Boston, Massachusetts., Buckstein R; Division of Medical Oncology/Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Carraway HE; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Churpek JE; Division of Haematology, Oncology, and Palliative Care, Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin., Daver NG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas., DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, Maryland., Efficace F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Fenaux P; Service d'hématologie, Hôpital Saint-Louis (Assistance Publique Hôpitaux de Paris), Université de Paris-Cité, Paris, France., Figueroa ME; Biochemistry & Molecular Biology, Sylvester Comprehensive Cancer Center. University of Miami Miller School of Medicine, Miami, Florida., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas., Gore SD; Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland., Greenberg PL; Division of Hematology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut., Hourigan CS; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia., Kim TK; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Kim N; NCI, NIH, Bethesda, Maryland., Komrokji RS; Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Kutchroo VK; Brigham and Women's Hospital, Boston, Massachusetts., List AF; Chief Scientific Officer, Stelexis Therapeutics, New York, New York., Little RF; Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland., Majeti R; Division of Hematology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Nazha A; Department of Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Nimer SD; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida., Odenike O; Leukemia Program, Section of Hematology/Oncology, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Padron E; Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Platzbecker U; Department of Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany., Della Porta MG; IRCCS Humanitas Research Hospital, Department of Biomedical Sciences, Humanitas University, Milan, Italy., Roboz GJ; Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York., Sallman DA; Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Santini V; Myelodysplastic Syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy., Sanz G; Health Research Institute La Fe, Valencia, Spain; Hospital Universitario y Politécnico La Fe, Valencia, Spain; CIBERONC, IS Carlos III, Madrid, Spain., Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Sekeres MA; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida., Stahl M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Starczynowski DT; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, Ohio., Steensma DP; David Steensma LLC, Cambridge, Massachusetts., Taylor J; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida., Abdel-Wahab O; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York., Wei AH; Department of Haematology, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Victoria, Australia., Xie Z; Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Xu ML; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut., Hasserjian RP; Department of Pathology, Massachusetts General Hospital Brigham, Boston, Massachusetts., Loghavi S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: Sloghavi@mdanderson.org.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Sep 23; Vol. 37 (12), pp. 100615. Date of Electronic Publication: 2024 Sep 23.
Autor:
Patel AA; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL., Yoon JJ; Division of Hematologic Malignancies, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA., Johnston H; Department of Medicine, Internal Medicine Residency, University of Chicago, Chicago, IL., Davidson MB; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Shallis RM; Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale Cancer Center, New Haven, CT., Chen EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Burkart M; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC., Oh TS; Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Iyer SG; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Madarang E; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Muthiah C; Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI., Gross I; University of Chicago Comprehensive Cancer Center, Chicago, IL., Dean R; University of Chicago Comprehensive Cancer Center, Chicago, IL., Kassner J; Memorial Sloan Kettering Cancer Center, New York, NY., Viswabandya A; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Madero-Marroquin R; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL., Rampal RK; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Guru Murthy GS; Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI., Bradley T; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Abaza Y; Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gupta V; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Pettit KM; Division of Hematology and Medical Oncology, Department of Internal Medicine, University of Michigan Medical School, Michigan Medicine, Ann Arbor, MI., Cursio JF; Department of Public Health Sciences, University of Chicago, Chicago, IL., Odenike O; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL.
Publikováno v:
Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3468-3477.
Autor:
Bewersdorf JP; Section of Hematology, Department of Internal Medicine, Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA. jan.bewersdorf@yale.edu.; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. jan.bewersdorf@yale.edu., Shallis RM; Section of Hematology, Department of Internal Medicine, Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA., Sharon E; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Park S; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Ramaswamy R; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Roe CE; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.; Vanderbilt Center for Immunobiology, Vanderbilt University, Nashville, TN, USA., Irish JM; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.; Vanderbilt Center for Immunobiology, Vanderbilt University, Nashville, TN, USA., Caldwell A; Section of Hematology, Department of Internal Medicine, Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA., Wei W; Section of Hematology, Department of Internal Medicine, Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA., Yacoub A; The Division of Hematologic Malignancies and Cellular Therapeutics (HMCT), The University of Kansas Cancer Center, Westwood, KS, USA., Madanat YF; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Zeidner JF; Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Altman JK; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA., Odenike O; University of Chicago, Chicago, IL, USA., Yerrabothala S; Hitchcock Cancer Center, Dartmouth University, Lebanon, NH, USA., Kovacsovics T; University of Utah, Huntsman Cancer Center, Salt Lake City, UT, USA., Podoltsev NA; Section of Hematology, Department of Internal Medicine, Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA., Halene S; Section of Hematology, Department of Internal Medicine, Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA., Little RF; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Piekarz R; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Gore SD; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Kim TK; Section of Hematology, Department of Internal Medicine, Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA. tae.k.kim@vumc.org.; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. tae.k.kim@vumc.org.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. tae.k.kim@vumc.org.; Vanderbilt Center for Immunobiology, Vanderbilt University, Nashville, TN, USA. tae.k.kim@vumc.org., Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA. amer.zeidan@yale.edu.; Hematology Section, Department of Internal Medicine, Yale School of Medicine, Yale University, 333 Cedar Street, PO Box 208028, New Haven, CT, 06520-8028, USA. amer.zeidan@yale.edu.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Jan; Vol. 103 (1), pp. 105-116. Date of Electronic Publication: 2023 Dec 01.
Autor:
Madero-Marroquin R; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Dworkin E; Department of Pharmacy, University of Chicago Medicine, Chicago, IL, USA., Weiner H; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Saygin C; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Nawas MT; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Drazer MW; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., DuVall AS; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Kosuri S; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Thirman MJ; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Odenike O; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Stock W; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Larson RA; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Patel AA; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Jun; Vol. 65 (6), pp. 864-867. Date of Electronic Publication: 2024 Mar 05.